Hey, agencies—last call for the MM&M A-to-Z Survey 2013!

Share this article:
Hey, agencies—last call for the MM&M A-to-Z Survey 2013!
Hey, agencies—last call for the MM&M A-to-Z Survey 2013!

Submit your information NOW for the MM&M Agency A-to-Z 2013.

The Agency A-to-Z is the definitive annual directory of healthcare agencies and is an important part of MM&M's Agency Issue, published in July. Around 150 agencies appeared in last year's A-to-Z. This year, info is again being collected online. A basic listing is FREE. You'll also have an opportunity to enhance your listing with a variety of options.

CLICK HERE to submit your information. Please complete all applicable sections.

The deadline for survey entries is TOMORROW!

For questions about the survey, please contact Kevin McCaffrey at (646) 638-6149 or email kevin.mccaffrey@haymarketmedia.com.

For further information about advertising in the Agency Issue, contact Doreen Gates at (267) 477-1151 or email doreen.gates@haymarketmedia.com.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...